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Stimulation of actin stress fibre formation mediated by activation
of phospholipase D
Michael J. Cross*, Sally Roberts*, Anne J. Ridley†, Matthew N. Hodgkin*,
Allison Stewart*, Lena Claesson-Welsh‡ and Michael J.O. Wakelam*
Background: Agonist-stimulated phospholipase D (PLD) catalyzes the hydrolysis
of phosphatidylcholine, generating the putative messenger phosphatidate (PA).
Proposed functions for PA, and hence for PLD, include kinase activation, the
regulation of small molecular weight GTP-binding proteins, actin polymerization
and secretion. It has not been possible to define a physiological function for PLD
activation as it is generally stimulated together with other signalling pathways,
such as those involving phospholipases A2 and C, phosphatidylinositide (PI) 3-
kinase and the p21ras/mitogen-activated protein (MAP) kinase cascade.
Results: We report that, in porcine aortic endothelial (PAE) cells, lysophosphatidic
acid (LPA) stimulated PLD activity and rapidly generated PA in the absence of
other phospholipase, PI 3-kinase or MAP kinase activities. PLD activation was
controlled by a tyrosine kinase-regulated pathway. LPA also stimulated actin stress
fibre formation, but was inhibited by butan-1-ol; the alcohol also reduced the
accumulation of PA. The addition of PA to cells did not stimulate PLD activity, but
did cause stress fibre formation in a manner that was insensitive to butan-1-ol.
Stimulation of stress fibre formation by LPA and PA was sensitive to genistein, and
was inhibited by micro-injection of the Rho-inhibiting C3 exotoxin into PAE cells.
Conclusions: This study provides the first clear demonstration of a physiological
role for PLD activity. In PAE cells, the stimulation of actin stress fibre formation
was a consequence of PA generation and, therefore, PLD activation. The results
suggest that PA generation is upstream of Rho activation, and imply a role for
PLD in the regulation of Rho-mediated pathways.
Background
The stimulation of cells by growth factors, hormones and
other agonists is mediated by the activation of intracellular
signal transduction pathways. In particular, membrane-
associated phospholipases have been shown to generate a
range of second messenger molecules. Three separate
phospholipase activities have been identified in stimulated
cells: a phospholipase C (PLC), which hydrolyzes phos-
phatidylinositol 4,5-bisphosphate (PIP2); a phospholipase
A2 (PLA2), which hydrolyzes phosphatidylcholine (PC);
and a phospholipase D (PLD), which also hydrolyzes PC.
In addition to these lipid-hydrolyzing enzymes, growth
factors also stimulate the lipid phosphorylating enzyme
phosphoinositide (PI) 3-kinase [1]. 
The roles of the PIP2-derived second messengers, inositol
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), in
mediating cellular processes requiring calcium mobiliza-
tion and increased protein phosphorylation have been elu-
cidated [1]. However, evidence for a physiological function
for the PLD product, phosphatidate (PA), is limited to in
vitro studies. These reports have led to suggestions such as
the existence of a PA-activated protein kinase [2] and
effects upon small molecular weight GTP-binding proteins
[3]. Progress in elucidating a function for PLD has been
hampered by the absence of cellular systems where this
phospholipase can be studied in the absence of the activa-
tion of other lipid metabolising enzymes. The importance
of such a system is emphasized by the fact that PA can be
generated in cells by DAG kinase from PIP2-derived DAG. 
Three small Ras-related GTP-binding proteins — Rho,
Rac and Arf — have recently been implicated in the regu-
lation of phospholipases. It has been proposed that Rac is
required for epidermal growth factor (EGF)-induced
arachidonate release in fibroblasts, suggesting that Rac
could regulate PLA2 activity in cells [4]. Both Arf and Rho
have been proposed to regulate PLD activity: Arf6 stimu-
lates PLD activity in cell extracts [5,6], whereas an
inhibitor of Rho and Rac, RhoGDI (Rho guanine
nucleotide dissociation inhibitor), inhibits PLD activity
[7]. This inhibitory effect can be reversed by the addition
of recombinant Rho, leading to the suggestion that Rho
regulates PLD activity directly; so far, however, there is
no evidence that Rho regulates PLD activity in cells. Rho
has been shown to mediate several cellular responses to
growth factors, including actin reorganization [8], activa-
tion of PI 4-phosphate 5-kinase [9], and activation of
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signalling pathways regulating transcription [10]. The
signalling pathways linking Rho to growth-factor receptors
and to these cellular responses have not yet been eluci-
dated, although there is evidence that tyrosine kinases are
required both for activation of Rho by lysophosphatidic
acid (LPA) [11], and downstream of Rho for the formation
of stress fibres [12]. Rac-induced arachidonic acid release
has also been suggested to lead to Rho activation [4]. In
this paper, we report the activation of PLD by lysophos-
phatidic acid (LPA) in porcine aortic endothelial (PAE)
cells, in the absence of the stimulation of other phospho-
lipid-metabolizing enzymes, and demonstrate that PLD
acts upstream of Rho in mediating the formation of actin
stress fibres. 
Results
LPA stimulates PLD activity in the absence of other lipid
signalling pathways
The stimulation of many different cell types with LPA has
been shown to induce the activation of a range of signalling
enzymes [13]. In PAE cells, however, LPA did not stimu-
late PI-PLC activity and did not activate phospholipase A2.
Furthermore, PI 3-kinase activity in anti-p85 subunit
immunoprecipitates was not stimulated by LPA. The gen-
eration of 3-phosphorylated lipids was examined in
[32P]phosphate-labelled cells, and no stimulation was
observed in response to LPA (data from two independent
experiments, d.p.m. in PIP3: 30 seconds at basal level, 1992
and 1884; 30 seconds with 10 mM LPA, 2199 and 1979;
5 minutes basal, 2113 and 1804; 5 minutes with LPA, 2379
and 1803; 5 minutes with 10 % fetal calf serum, 2638). The
method used to examine changes in the 3-phosphorylated
lipids was also used to examine PIP2 labelling in control
and stimulated cells, and from this data it was clear that
LPA also did not stimulate PIP2 generation (data not
shown).
The LPA-stimulated PLD activity in PAE cells was deter-
mined by the accumulation of [3H]phosphatidylbutanol in
[3H]palmitate-labelled cells incubated in the presence of
butan-1-ol. As shown in Figure 1, PLD activation was rapid
but transient, being detectable by 20 seconds and reaching
a maximum within 1 minute. This activation was dose-
dependent, with an approximate EC50 of 3 mM; however,
the EC50 value obtained was dependent upon the medium
composition, as the lipid binds strongly to albumin.
In addition to determining PLD activation by phos-
phatidylalcohol accumulation, the mass of PA and of DAG
was quantified in cells stimulated with 10 mM LPA.
Figure 1
Stimulation of PLD activity by LPA in PAE cells. [3H]palmitate-labelled
cells, preincubated with 30 mM butan-1-ol for 5 min, were stimulated
with 10 mM LPA for increasing times and the generation of
[3H]phosphatidylbutanol determined. Results are expressed as
radioactivity in [3H]phosphatidylbutanol (mean d.p.m. ± S.D., n = 3)
from a single experiment representative of two. 
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Figure 2
LPA stimulates PA and DAG generation in PAE cells. (a) Time course
of LPA-stimulated PA generation. Cells were stimulated for the times
indicated with 10 mM LPA. Results are expressed as pmoles PA per
nmole of total phospholipid (n = 2) from a single experiment
representative of two. (b) Time course of LPA-stimulated DAG
generation. Cells were stimulated for the times indicated with 10 mM
LPA. Results are expressed as pmoles DAG per nmole of phospholipid
(n = 2) from a single experiment representative of two. 
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Significant generation of PA was apparent after
20 seconds, maximal after 1 minute, and returned towards
the basal level by 5 minutes (Fig. 2a). The mass of DAG
was unchanged after 20 seconds, but was significantly
increased after 1 minute and remained elevated for a
longer period than PA (Fig. 2b). When the cells were stim-
ulated with 3mM LPA, a smaller amount of PA was pro-
duced in the absence of DAG generation. These
observations are consistent with the sole activation of
PLD, and the production of DAG solely from PA. 
PLD activity has been reported to be regulated by both
protein kinases C (PKC) and protein tyrosine kinases
(TK). To investigate the mechanism by which LPA stim-
ulates PLD activity, PAE cells were pre-incubated with
the selective PKC inhibitor Ro 31-8220 or the TK
inhibitor genistein prior to stimulation. As shown in
Figure 3a, the PKC inhibitor had essentially no inhibitory
effect upon LPA-stimulated PLD activity, whereas the
TK inhibitor completely blocked PLD stimulation. As a
control, we confirmed that the stimulation of PLD
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Effect of inhibitors upon LPA-stimulated PLD activity and PA mass. (a)
Effect of inhibitors upon LPA-stimulated PLD activity. [3H]palmitate-
labelled cells were incubated with pertussis toxin (25 ng ml–1 for 18 h),
genistein (100 mm for 30 min) or Ro31-8220 (10 mM for 10 min) prior
to the addition of 10 mM LPA in the presence of 30 mM butan-1-ol for
5 min. Results are expressed as radioactivity in [3H]phosphatidyl-
butanol (mean d.p.m. ± S.D., n = 3) from a single experiment
representative of three. (b) Effect of PA and DOG on PLD activity.
[3H]palmitate-labelled cells were incubated for 1 min with 10 mM
butan-1-ol prior to stimulation for 5 min with 3 mM LPA, PA or DOG.
Results are expressed as radioactivity in [3H]phosphatidylbutanol
(mean d.p.m. ± S.D., n = 3) from a single experiment representative of
two. (c) Effect of modulators of LPA-stimulated PLD activity on PA
generation. Cells were incubated with either pertussis toxin (25 ng ml–1
for 18 h), genistein (100 mm for 30 min), butan-1-ol (10 mM for 1 min)
or butan-2-ol (10 mM for 1 min), prior to stimulation with 3 mM LPA for
1 min. Results are expressed as PA generation (% increase over basal)
from a single experiment (n = 3) representative of two. Mean basal PA
concentration = 2.41 ± 0.3 pmoles PA per nmole total phospholipid.
(d) Effect of alcohols on LPA-stimulated [3H]phosphatidylbutanol
generation. [3H]palmitate-labelled cells were incubated for 1 min with
10 mM butan-1-ol, 10 mM butan-2-ol, or 10 mM butan-1-ol plus 10 mM
butan-2-ol, prior to the addition of 3 mM LPA for 5 min. Results are
expressed as radioactivity in [3H]phosphatidylbutanol (mean d.p.m. ±
S.D., n = 3) from a single experiment representative of two.
activity by a phorbol ester, phorbol myristate acetate
(PMA), was completely inhibited by Ro 31-8220 (data not
shown). Pre-treatment of the cells with pertussis toxin
also had no effect upon LPA-stimulated PLD activity
(Fig. 3a). This is consistent with there being no role for
the heterotrimeric GTP-binding proteins  Gi or Go in
coupling the LPA receptor to PLD. The inhibition of
PLD by genistein was observed at both high and low
LPA concentrations and in the presence of 10 or 30 mM
butan-1-ol. The stimulation of PLD activity by LPA was
specific, as PA was unable to stimulate the accumulation
of phosphatidylbutanol (Fig. 3b).
The inhibitory effect of genistein, and the lack of effect of
pertussis toxin, upon LPA-stimulated phosphatidylalcohol
production was also observed when PA mass was measured
(Fig. 3c). The inclusion of butan-1-ol significantly reduced
LPA-stimulated PA generation, whereas butan-2-ol caused
only a small reduction in PA mass (Fig. 3d). These results
are consistent with the use of butan-1-ol as a nucleophilic
acceptor in the transphosphatidylation reaction uniquely
catalyzed by PLD (secondary alcohols, such as butan-2-ol,
cannot be used by the phospholipase).
LPA is not a mitogen for PAE cells
LPA stimulates a mitogenic response in many cell types.
When added to PAE cells, however, LPA had no effect
upon the incorporation of [3H]thymidine; in contrast,
serum stimulated significant [3H]thymidine incorporation
(acid-insoluble d.p.m.: control cells, 5037 ± 422; plus
10 mM LPA, 5489 ± 148; plus 5 % foetal calf serum,
18821 ± 2323). It has also been reported that LPA-stimu-
lated mitogenesis is associated with an increase in GTP-
bound p21ras and the consequent activation of MAP kinase
[14]. In the PAE cells, LPA did not stimulate MAP kinase
phosphorylation, as determined electrophoretically and by
enzyme activity in anti-ERK1/2 immunoprecipitates (data
not shown).
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Figure 4
Effect of LPA on actin reorganization. PAE
cells were stimulated with 10 mM LPA for
the times indicated, fixed and stained with
rhodamine-conjugated phalloidin. (a,c,d,f,g)
Bar, shown in (g), represents 30 mm. 
(b,e) Cells treated with 10 mM LPA for the
times indicated, and photographed at higher
magnification; bar represents 40 mm. 
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LPA stimulates actin stress fibre formation
Stimulation of the PAE cells with LPA resulted in an
increase in actin stress fibre formation that was detected by
the binding of rhodamine-conjugated phalloidin. As shown
in Figure 4, the addition of the phospholipid caused an
increase in fibre formation within 20 seconds, which
reached a maximum by 1–2 minutes and then declined. 
As the activation of PLD was the only detectable signalling
pathway stimulated by LPA, the effects of modulators of
PLD activity upon stress fibre formation were examined.
Genistein completely inhibited stress fibre formation in
both unstimulated and LPA-stimulated cells (Fig. 5),
whereas neither Ro 31-8220 nor pertussis toxin had any
effect (data not shown). LPA-stimulated stress fibre forma-
tion was inhibited by butan-1-ol (Fig. 5), which also
reduced the basal level of stress fibres. (The primary
alcohol, which does not inhibit PLD, induces the formation
of phosphatidylalcohol and thereby reduces stimulated PA
mass; see Fig. 3c.) The secondary alcohol butan-2-ol had no
Figure 5
Effect of modulators of LPA-stimulated PA
mass on stress fibre formation in PAE cells.
(a) Control cells. (c,e,g) Cells were incubated
for 1 min with either (c) 10 mM butan-1-ol or
(e) 10 mM butan-2-ol, or (g) for 30 min with
100 mM genistein. (b,d,f,h) Cells shown in
(a,c,e,g) after the addition of 3 mM LPA for
1 min. Cells were stained for actin filaments
with rhodamine-conjugated phalloidin. Bar
represents 30 mm.
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effect on PA formation and only a small effect upon LPA-
stimulated stress fibre formation; this latter effect  was also
observed in unstimulated cells (Fig. 5).
As a reduction in LPA-stimulated PA generation was
inhibitory to the increase in stress fibre formation, the
effect of adding PA in micellar form was examined.
Thin-layer chromatographic analysis confirmed that the
dioleoyl-PA used in this work was LPA-free (data not
shown), and it was confirmed that PA was not stimulating
the cells through the LPA or another receptor — PA did
not stimulate PLD activity (Fig. 3b). As shown in Figure
6, the addition of PA to the medium stimulated stress
fibre formation; this effect was not inhibited by the
addition of butan-1-ol but was fully inhibited by genis-
tein. The addition of cell-permeable dioctanylglycerol
(DOG) caused only a small increase in stress fibres (Fig.
6), an effect that can be explained by the conversion of a
proportion of this lipid to PA by the action of DAG
kinase (Fig. 3c). 
Figure 6
Effect of PA and DOG on stress fibre
formation in PAE cells. (a) Control cells. (b,e)
Cells were stimulated with (b) 3 mM PA or (e)
3 mM DOG for 5 min. (c,d) Cells were
preincubated with (c) 10 mM butan-1-ol for 1
min, or with (d) 100 mM genistein for 30 min,
before the addition of 3 mM PA for 5 min.
Cells were stained for actin filaments with
rhodamine-conjugated phalloidin. Bar
represents 30 mm.
Figure 7
PA- and LPA-induced stress fibre formation is inhibited by C3
transferase. Serum-starved PAE cells were microinjected with C3
transferase (8 mg ml–1) and the marker protein rat IgG (0.5 mg ml–1).
Cells were either fixed after 20 min (a), or stimulated after 15 min with
LPA (10 mM) for 2 min (b), or with PA (10 mM) for 5 min (c). Actin
filaments were visualized with TRITC-labelled phalloidin. Arrows
indicate injected cells, identified by staining with FITC-conjugated goat
anti-rat IgG. 
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LPA- and PA-stimulated stress fibre formation is
dependent upon Rho
In Swiss 3T3 cells, LPA-stimulated stress fibre formation
has been shown to be mediated by the small GTP-binding
protein Rho [8], and it has been suggested that Rho may
activate PLD in certain cell types [15]. We therefore
investigated the role of Rho in the activation of stress fibre
formation in PAE cells by microinjecting the Rho-selec-
tive Clostridium botulinum exoenzyme C3 transferase. C3
ADP-ribosylates Rho proteins and thereby inactivates
them [16,17]. The injection of C3 inhibited the activation
of stress fibre formation by both LPA and PA (Fig. 7),
suggesting that Rho is activated as a consequence of PLD
activation.
Discussion
Stimulation of cells via transmembrane receptors activates
a plethora of signal transduction pathways and down-
stream biochemical responses. It is difficult, therefore, to
assign precise cellular functions to the activation of a par-
ticular pathway. Experiments using selective inhibitors,
dominant-negative gene products and mutant receptors
have provided indications of functional roles for signal
transduction pathways, but the ideal situation where the
activation of an individual pathway can be examined in
isolation is rarely available.
In the PAE cell line, LPA activated PLD in the absence of
stimulation of other phospholipid signalling pathways.
This was confirmed by measuring PI-PLC, PI-3-kinase
and PC-PLA2 activities in stimulated cells. Further evi-
dence for this restricted phospholipase activation was pro-
vided by mass measurements of PA and DAG (Fig. 2). As
the addition of exogenous PA was unable to stimulate
PLD, the activation of the phospholipase by LPA was
mediated through binding to a specific cell-surface recep-
tor. Signalling through the putative LPA receptor has been
reported to involve both pertussis toxin-sensitive and
insensitive GTP-binding proteins  [13]. Whether this
involves different forms of the LPA receptor is unclear; in
the PAE cells, however, the LPA-stimulated responses
were insensitive to pertussis toxin. LPA has been reported
to activate non-receptor tyrosine kinases [13], and the stim-
ulated PLD activity was sensitive to the tyrosine kinase
inhibitor genistein but insensitive to inhibition of protein
kinase C (Fig. 3). Both of these kinase pathways have been
implicated in the control of PLD, with one or other
pathway dominating depending upon cell type. There is
also increasing evidence for at least two isoforms of PLD
[18] — hence it is possible that one form is regulated by
LPA-stimulated tyrosine phosphorylation in PAE cells. It
has also been proposed that PLD activity is regulated by
the GTP-binding proteins Arf [5,6] and Rho [7,15,19]. In
an in vitro assay using PAE extracts,  the activation of PLD
by recombinant Arf was detected (our unpublished obser-
vations), and it is possible, therefore, that Arf-activated
PLD is stimulated by LPA in PAE cells. Thus, one role for
tyrosine phosphorylation in PAE cells may be in the activa-
tion of Arf. PAE cells possess a PKC-activatable PLD, as
demonstrated by the stimulation of [3H]phosphatidylbu-
tanol formation by PMA; this stimulation was inhibited by
incubation of the cells with Ro 318220.
The essential role of the PLD pathway in PA generation
was demonstrated by the use of butan-1-ol and butan-2-ol.
The primary alcohol butan-1-ol can function as a nucle-
ophilic acceptor in the PLD-catalyzed transphosphatidyla-
tion reaction, whereas butan-2-ol, a secondary alcohol,
cannot. The primary alcohol significantly reduced LPA-
stimulated PA generation, with a corresponding increase
in the level of phosphatidylbutanol. The secondary
alcohol had only a small inhibitory effect upon PA forma-
tion, which was probably a reflection of a non-specific
alcohol effect, and was unable to support the formation of
the phosphatidylalcohol. 
Further examination of the effects of LPA upon PAE cells
showed that the phospholipid did not activate mitogene-
sis, as assessed by incorporation of [3H]thymidine, nor did
it stimulate MAP kinase activity. These results are consis-
tent with previous observations that Ras activation and
subsequent MAP kinase activation is essential for LPA-
induced mitogenesis [13]. LPA did stimulate actin stress
fibre formation in PAE cells, however, as has been
observed previously for Swiss 3T3 cells [8]. Stress fibre
formation was observed in the absence of an effect upon
membrane ruffling, confirming that stress fibre formation
and ruffling are regulated independently. 
The stimulation of stress fibre formation by LPA in PAE
cells was dependent upon the activation of PLD and the
generation of PA. Genistein inhibited LPA-stimulated
PLD activity and stress fibre formation, whereas pertussis
toxin and Ro 31-8220 were without effect. Butan-1-ol
inhibited LPA-stimulated stress fibre formation and
reduced the level of stress fibres in unstimulated cells;
butan-2-ol caused only a small decrease in both control and
stimulated cells that correlated with effects upon PA for-
mation. The basal level of stress fibres in serum-starved
PAE cells was higher than that in Swiss 3T3 cells, which
may reflect the much higher basal activity of PLD in the
endothelial compared to the fibroblast cell [20]. This pro-
posal is supported by the reduction in the level of stress
fibres in unstimulated PAE cells incubated with butan-1-ol
but not butan-2-ol. In LPA-stimulated Swiss 3T3 cells,
stress fibre formation was not inhibited by butan-1-ol (data
not shown), probably because of the activation of parallel
lipid signalling pathways.
It was reasoned that, as the inhibition of PLD activity
(and hence PA generation) prevented LPA-stimulated
stress fibre formation, the direct addition of PA should
stimulate an increase in fibres; as shown in Figure 6, this
effect was observed. The addition of a cell-permeable
DAG had only a small effect, which most likely resulted
from conversion of the DAG to PA. Significantly, the acti-
vation of stress fibre formation by PA was not inhibited by
butan-1-ol, supporting a specific role for PA downstream
of PLD activation; the PA must therefore have either
entered the cell or been incorporated into the cell mem-
brane [21,22] to produce its effects. LPA and PA have pre-
viously been shown to activate stress fibre formation in
IIC9 cells [23,24], but it was not possible to definitively
assign a role for PLD as other phospholipases were also
activated. Treatment of cells with PMA has been reported
to inhibit rather than stimulate stress fibre formation [12];
this effect was probably due to activation of many path-
ways by the phorbol ester, in addition to PLD.
In Swiss 3T3 cells, a critical role for Rho in the formation of
actin stress fibres has been demonstrated [8]. It was shown
subsequently that Rho-induced stress fibre formation in
Swiss 3T3 cells was sensitive to genistein [12]. To assess
the importance of Rho in LPA-stimulated stress fibre for-
mation in PAE cells, we microinjected the cells with
Clostridium botulinum exoenzyme C3 transferase, which
inactivates Rho proteins. In PAE cells injected with C3, no
stress fibre formation was observed in response to LPA or
PA and the fibres present in the unstimulated cells disap-
peared (Fig. 7); these results demonstrate an absolute
requirement for active Rho in stress fibre formation. As the
PA-stimulated response was also inhibited by C3, LPA-
stimulated PA production, catalyzed by PLD, must act
upstream of Rho. It was unclear whether Rho was activated
directly or indirectly by PA; however, an effect of PA, but
not of LPA, upon the complex of Rho-GDI with Rho and
other members of the Rho family has been reported [3].
The role of Rho in regulating stress fibre formation in
eukaryotic cells appears to be universally accepted. A
feature of reports of stress fibre formation is that, in all
cases, the stimulants used — such as LPA, bombesin,
platelet-derived growth factor and vanadate in Swiss 3T3
cells, or a-thrombin in IIC9 cells [8,23,25,26] — are also
known to activate PLD [27,28]. It is possible, therefore,
that a major role for PLD activation is the stimulation of
actin stress fibre formation through Rho, although it
remains to be determined exactly how Rho activity is
regulated. PLD activity has been demonstrated in chemo-
tactic peptide-stimulated neutrophils [29] and IgE-
stimulated secretion in mast cells [28], concurrent with
actin cytoskeletal reorganization. It has also been sug-
gested that an increase in PLD activity was responsible for
an increase in invasiveness of carcinoma and hepatoma
cells [30]. Whether this is the sole function of PLD activa-
tion is unclear, indeed it has been suggested that PLD
activation is important in secretory fusion events [29],
which may reflect differing functions for the different
PLD isoforms. It is also probable that there are alternative
mechanisms of Rho activation. In particular the activation
of Rac can lead to a stimulation of Rho [31], and it has
recently been proposed that this was a consequence of
Rac-stimulated PLA2 activity generating leukotrienes,
which then activated Rho [4]. This pathway was not oper-
ating in LPA-stimulated PAE cells, where no PLA2 stimu-
lation was observed; however, in systems where
stimulated leukotriene formation is involved in Rho acti-
vation, this could be mediated by PLD if the leukotriene
activated a cell-surface receptor.
Conclusions
This study demonstrates a physiological role for PLD
activity. In PAE cells, the stimulation of actin stress fibre
formation was a consequence of PA generation and, there-
fore, PLD activation. The results suggest that PA genera-
tion is upstream of Rho activation, and imply a role for
PLD in the regulation of Rho-mediated pathways. Figure
8 shows a  schematic model for LPA-stimulated stress
fibre formation, as suggested by the results presented in
this paper. LPA stimulates PLD activity by activating a
tyrosine kinase that stimulates the activity of Arf, perhaps
by activating guanine nucleotide exchange. The PLD-
derived PA then activates Rho, which can stimulate actin
stress fibre formation via the activation of a second,
distinct, genistein-sensitive tyrosine kinase. This model is
consistent with a recent report proposing that two distinct
tyrosine kinases are involved in LPA-stimulated stress
fibre formation [26].
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Figure 8
Schematic representation of the LPA-stimulated signalling cascade
resulting in stress fibre formation in PAE cells.
LPA Receptor TK
ArfPLDPA
Rho TK
Genistein
inhibited
C3 inhibited
Butan-1-ol
inhibited
Stress fibre
formation
Genistein
inhibited
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Materials and methods
Materials
Cell culture media were obtained from Gibco-BRL. Phospholipids were
obtained from Sigma. The anti-p85a antibody clone U13 was obtained
from Serotec, protein G–Sepharose was obtained from Pharmacia.
Radiochemicals were obtained from Amersham International. The rho-
damine-conjugated phalloidin was obtained from Molecular Probes.
Cell culture
Cells were maintained in Ham’s F-12 containing Glutamax 1, supple-
mented with 10 % (v/v) foetal calf serum at 37 °C in a humidified
atmosphere of air/CO2 (19:1). Cells were routinely passaged when
subconfluent. For phospholipase assays, cells were seeded into 24-
well plates at a density of 4 × 104 ml–1 and grown for 48 h. They were
then quiesced in medium containing 1 % (v/v) fetal calf serum and
appropriate radiolabel for 24 h.
Assay of phospholipase activity in whole cells
Phospholipase C and A2 activities were determined as described previ-
ously [32,33]. For phospholipase D measurements, cells labelled with
4 mCi ml–1 [9,10(n)-3H]palmitic acid were washed in Hank’s buffered
saline solution (pH 7.4), containing 20 mM Hepes, 10 mM glucose and
0.1 % (w/v) BSA. Incubations were initiated by the addition of agonist
in the presence of butanol and terminated by aspiration and addition of
ice-cold methanol. After extraction of the lipids in chloroform/methanol,
[3H]phosphatidylbutanol was separated by thin-layer chromatography
as described previously [20].
Measurement of PI 3-kinase activity 
In vitro kinase activity was determined in immunoprecipitates prepared
from PAE cell lysates with U13 hybridoma supernatant essentially as
described by Jackson et al. [34]. 3-phosphorylated lipids were deter-
mined in cells labelled for 90 min in 0.25 mCi ml–1 [32P]phosphate at
37 °C. Following stimulation lipids were extracted and then deacylated
with methylamine reagent (33 % in methanol at 56 °C for 50 min); the
glycero-phosphates were then deglycerated using mild sodium perio-
date treatment [35]. Phosphate-containing head groups were sepa-
rated by anion exchange HPLC on a 25 cm partisphere 5 SAX column
eluted with a linear gradient of ammonium dihydrogen phosphate
(0.5 M, pH 3.8 with phosphoric acid) in water at 1 ml min–1 over
110 min. Fractions were collected every 0.5 min and 32P-radioactivity
was determined by liquid scintillation counting. 
Measurement of phosphatidate and DAG mass
Lipids were extracted from cells and separated by thin layer chro-
matography with PA being visualized by Coomassie blue staining [36],
PA mass was calculated by comparison with standards following den-
sitometry. DAG was determined by radioenzymatic assay using
Escherichia coli DAG kinase as described previously [37]. All mea-
surements of PA and DAG were normalized to total phospholipid phos-
phorous in the sample measured as described previously.
Fluorescence staining of actin filaments and microinjection
PAE cells were seeded onto ‘microspot’ adherent microscope slides at
a density of 3 × 105 cells dish in 100 mm petri dishes and grown for
24 h to maintain subconfluency. They were quiesced by replacing the
medium with serum-free Ham’s F-12 for 24 h. Cells were washed in
Hank’s buffered saline solution (pH 7.4), containing 20 mM Hepes,
10 mM glucose and 0.1 % (w/v) BSA and stimulated with agonist;
incubations were terminated by washing briefly in ice-cold phosphate
buffered saline (PBS). Cells were then fixed in 4 % para-formaldehyde
for 8 min. The slides were washed twice in PBS and the cells perme-
abilized by immersing in acetone at –20 °C for 10 min. The slides were
air dried and the cells stained with 0.33 mM rhodamine-conjugated
phalloidin for 30 min, washed in PBS and mounted in
glycerol/DABCO. Actin polymerization was visualized by fluorescence
microscopy.
For microinjection studies, cells (104) were seeded onto glass cover-
slips in 15 mm diameter dishes and cultured for 24 h. They were qui-
esced by replacing the medium with serum-free Ham’s F-12 for 24 h.
The coverslips were transferred to Hank’s buffered saline solution (see
above) prior to microinjection. Cells were microinjected with C3 trans-
ferase (8 mg ml–1) and the marker protein rat IgG (0.5 mg ml–1), incu-
bated with phospholipids as above and stained for actin filaments as
described [8].
Measurement of [3H]thymidine incorporation.
[3H]thymidine incorporation was determined as trichloroacetic acid
insoluble radioactivity in cells quiesced in serum free HAM’s F-12 for
48 h and then stimulated in Ham’s F-12 containing 0.05 % (v/v) fetal
calf serum and 0.5 mCi ml–1 [3H]thymidine for 20 h. 
Measurement of in vitro MAP kinase activity
Cells were stimulated as above and lysates were prepared and
immunoprecipitated with a 1:100 dilution of rabbit anti-MAP kinase
antibody for 2 h at 4 °C. Kinase activity was determined as described
using myelin basic protein as the substrate [14]. 
Preparation of LPA and PA for experimental use
LPA was stored in CHCl3:CH3OH (19:1) containing 1 % acetic acid,
PA was stored in CHCl3:CH3OH (19:1). The lipids were dried in glass
tubes, Hanks’s buffered saline containing 0.1 % bovine serum albumin,
10 mM glucose and 20 mM Hepes (pH 7.4) was added and the lipids
solubilized by sonication in a bath sonicator for 1 min.
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